Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

  • Lounsbury Quoted in Social Work Today Article
    August 1, 2022 by Lucy Gardner Carson
    (AUGUST 1, 2022) Karen Lounsbury, Ph.D., professor of pharmacology and director of foundations and preclinical assessment, is quoted in an article in “Social Work Today” on integrating service delivery by medical or physical health providers, behavioral health providers, and social service providers.
  • Telegraph Quotes King on ‘Vermonters Taking Action Against Cancer’ Program
    July 31, 2022 by Lucy Gardner Carson
    (JULY 31, 2022) In response to statistics showing that lung cancer kills more Vermonters than breast, prostate, and colorectal cancers combined, family medicine professor John King, M.D., and colleagues at the UVM and Dartmouth Cancer Centers are spearheading a new community education program called Vermonters Taking Action Against Cancer, the (Nashua, N.H.) Telegraph reported.
    Read full story at The (Nashua, N.H.) Telegraph
  • The Cancer Letter Features Yates Reflecting on Starting UVM Cancer Center
    July 29, 2022 by Lucy Gardner Carson
    (JULY 29, 2022) Retired oncology professor Jerome Yates, M.D., spoke with Alexandria Carolan, a reporter with The Cancer Letter and associate editor of the Cancer History Project, about building a cancer center at the University of Vermont.
    Read full story at The Cancer Letter
  • Ehret Invested as Inaugural Asfaw Yemiru Green and Gold Professor in Global Health
    July 28, 2022 by Jennifer Nachbur and Christina Davenport
    Associate Professor of Pediatrics and neonatologist Danielle Ehret, M.D., M.P.H., was invested as the inaugural Asfaw Yemiru Green and Gold Professor in Global Health in a formal ceremony held at the University of Vermont’s Larner College of Medicine on July 28, 2022.
  • Diehl Comments to CT Insider on Yale’s Omicron-specific mRNA Vaccine
    July 28, 2022 by Lucy Gardner Carson
    (JULY 28, 2022) Sean Diehl, Ph.D., associate professor of microbiology and molecular genetics, spoke with CT Insider about an Omicron-specific mRNA vaccine developed by Yale scientists that creates a strong antibody response against subvariants BA.1 and BA.2.12.1.
    Read full story at CT Insider

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Questions?

Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!